Sertoli-leydig cell tumor are very rare and make up approximately 0.5% of all ovarian tumors. they typically produce androgen and clinical virilizati on is present in 70-85% of cases. We report a of Sertoli-leydig cell tumor without virilizati on.
INTRODUCTION
Sertoli-Leydig cell tumor(SLCT) is a rare ovarian tumor that belongs to the group of sex -cord stromal tumors. 1 Most tumors are unilateral, confi ned to the ovaries and are seen during the second and third decades of life. Only 2% are bilateral These tumors are characterized by the presence of testi cular structures that produce androgens.
CASE REPORT
A 23 yrs lady para 1+1 complained of amenorrhoea of 2 years. There was no history of abdominal lump and distension. She was on Depomedroxyprogesterone injecti on on and off for last 3 years. Her past medical and surgical history was not signifi cant. On abdominal examinati on there was mass of 18 week size, mobility was restricted, fi rm in consistency , non tender. On per speculum examinati on cervix was healthy. On per vaginal examinati on exact size of uterus couldn't be esti mated, mass was 18 week size.
USG revealed large multi septated mass 13.3x12x5.6 cm seen fi lling pelvic cavity. CA 125 was 30.8IU/ml, CEA was 5.6ng/ml ,LDH was 397U/l. CT scan of the abdomen revealed a large complex ovarian mass (left ovarian origin) suggesti ve of malignant lesion. On laparotomy Jelly like cyst with slight solid component seen measuring 20x20 cm in diameter, uterus was normal in size. Right tube and ovary were normal in size and texture. On cut secti on Serous fl uid of about 2 litres, multi ple septati on and projecti on like structure was seen. Post-operati ve period was uneventf ul. Histopathology shows Sertoli-Leydig cell tumour of intermediate diff erenti ati on with reti form and heterologous mucinous elements with low-grade dysplasia.
typically produce androgen and clinical virilizati on is noted in 70% to 85% of pati ents. Size of SLCTs varies greatly, Mean diameter is approximately 10 cm. Typically, they form fi rm, lobulated, yellow or tan, solid masses with a smooth external surface. Cysts may be conspicuous, parti cularly if the tumor contains heterologous mucinous elements or has a reti form component. Heterologous tumors with a prominent mucinous component may simulate mucinous cysti c tumors.
Tumors with a reti form component are oft en soft and spongy, or cysti c with large, edematous intraluminal polypoid excrescences simulati ng serous papillary tumors. Areas of hemorrhage and necrosis are uncommon, except in poorly diff erenti ated subtypes. In another study who had intermediate or poorly diff erenti ated SLCT, a survival rate of 92% was noted at both fi ve and 10 years.3 Fortunately, more than 97% of SLCTs are grade one (well diff erenti ated).
Most of these tumors are unilateral and diagnosed in grade one , the usual treatement is unilateral salpingo-oophorectomy and evaluati on of the contralateral ovary for pati ents who are in their reproducti ve years4. For older pati ents hysterectomy and bilateral salpingo-oohorectomy are appropriate.5
Adjuvent chemotherapy in grade 1 is given to those pati ents who have poorly diff erenti ated SLCT or SLCT with heterologous elements or a metastati c tumor of any histologic type.6 The BEP regimen is a comparati vely safe chemotherapeuti c regimen because it does not aff ect the ferti lity status of the pati ent.7
CONCLUSION
SLCT should always be considered in a young female pati ent who has symptoms of virilizati on and an ovarian mass on examinati on or investi gati on.
Heterologous mucinous elements Darker Sertoli cells (Red box) and Pink Leydig cells (Green box)

Reti form elongated tublules
Biphasic cellular components with darker Sertoli cells arranged in sheets, tubules and reti form formati ons and clusters of pink Leydig cell with abundant eosinophilic cytoplasm
